After Experiencing Extreme Volatility This Month, Does This Biopharma Stock Have Any Upside Left?

Shares of the relatively unknown biopharmaceutical company discussed in today’s article have experienced extreme volatility this month, hitting their all-time low on June 2^nd before proceeding to soar to their all-time high on June 10^th. The cause of this extreme volatility? Retail investor activity and enthusiasm surrounding the stock on social media platforms such as Reddit. But with the FDA having failed to approve the company’s lead pipeline candidate, is there any upside left for the stock? For a look at its prospects, CLICK HERE.